Fasting duration
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Male, age 50-80 years, stable weight three months prior to study inclusion, BMI: 30kg/m2 for obese subjects.
Exclusion criteria
Exclusion criteria: Use of any medication except for those related to treatment of components of the metabolic syndrome. Use of exogenous insulin or oral glucose lowering drugs Any actual medical condition except for treated hypothyroidism and the metabolic syndromeHistory of any psychiatric disorder Shift work Irregular sleep pattern Intensive sports (>3 h/week) Restrained eaters History of eating disorders (anorexia, binge eating, bulimia) Smoking, XTC, amphetamine or cocaine abuse Alcohol abuse (>3 units/day) Lactose intolerance Estimated glomerular filtration rate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Differences in cerebral availability of SERT and DAT (assessed by [123I]FP-CIT SPECT) after 12 vs 24 hours of fasting. | — |
Secondary
| Measure | Time frame |
|---|---|
| To determine the effect of the fasting duration on peripheral neuropeptides and hormones in relation to cerebral SERT and DAT availability and feeding behaviour To determine the effect of fasting duration on resting energy expenditure (REE) in relation to cerebral SERT and DAT availability and feeding behaviour To determine the effect of fasting duration on appetite and feeding behaviour in relation to cerebral SERT and DAT availability To determine whether fasting affects lean and obese subjects differently | — |
Countries
Netherlands